DekaBank Deutsche Girozentrale trimmed its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 13.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 342,625 shares of the real estate investment trust's stock after selling 52,768 shares during the quarter. DekaBank Deutsche Girozentrale's holdings in Healthpeak Properties were worth $6,847,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently made changes to their positions in DOC. Mizuho Bank Ltd. purchased a new position in shares of Healthpeak Properties in the 4th quarter worth about $28,000. Harvest Fund Management Co. Ltd purchased a new position in Healthpeak Properties in the 4th quarter worth about $30,000. Future Financial Wealth Managment LLC purchased a new position in Healthpeak Properties in the 1st quarter worth about $30,000. S.A. Mason LLC raised its position in Healthpeak Properties by 160.9% in the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock worth $30,000 after buying an additional 925 shares during the last quarter. Finally, Covestor Ltd grew its stake in shares of Healthpeak Properties by 173.8% during the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock valued at $37,000 after purchasing an additional 1,152 shares during the period. 93.57% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on the company. Argus reiterated a "buy" rating and set a $25.00 price objective on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Evercore ISI dropped their price target on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Scotiabank dropped their price target on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research note on Monday, May 12th. Wedbush decreased their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Finally, Robert W. Baird decreased their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $23.27.
View Our Latest Stock Report on Healthpeak Properties
Healthpeak Properties Stock Down 1.7%
DOC stock traded down $0.31 during trading on Tuesday, reaching $18.23. 4,856,997 shares of the company traded hands, compared to its average volume of 5,355,283. Healthpeak Properties, Inc. has a 12 month low of $16.64 and a 12 month high of $23.26. The business has a 50 day simple moving average of $17.47 and a 200 day simple moving average of $18.95. The company has a market capitalization of $12.66 billion, a price-to-earnings ratio of 45.58, a price-to-earnings-growth ratio of 2.10 and a beta of 1.03. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.35 and a current ratio of 1.35.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. The company had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. During the same period last year, the business posted $0.45 earnings per share. The firm's revenue was up 15.9% compared to the same quarter last year. On average, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
The business also recently declared a monthly dividend, which will be paid on Tuesday, September 30th. Investors of record on Friday, September 19th will be given a dividend of $0.1017 per share. This represents a $1.22 annualized dividend and a yield of 6.69%. The ex-dividend date is Friday, September 19th. Healthpeak Properties's dividend payout ratio is currently 305.00%.
Insider Buying and Selling at Healthpeak Properties
In related news, Director Tommy G. Thompson acquired 5,777 shares of Healthpeak Properties stock in a transaction that occurred on Wednesday, May 28th. The shares were purchased at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the completion of the transaction, the director owned 144,290 shares in the company, valued at $2,491,888.30. This represents a 4.17% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Scott M. Brinker bought 2,750 shares of the stock in a transaction that occurred on Friday, May 9th. The shares were bought at an average cost of $17.39 per share, with a total value of $47,822.50. Following the completion of the purchase, the chief executive officer directly owned 204,613 shares in the company, valued at $3,558,220.07. This represents a 1.36% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 29,764 shares of company stock valued at $521,909. Company insiders own 0.23% of the company's stock.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.